Author

Priya Narayanan

AbbVie (United States)ORCID 0000-0002-7020-5007Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anlu CheniD· 1 shared Darren C. PhillipsiD· 1 shared Eli Y. Andino-FrydmaniD· 1 shared Grace A. AlchemyiD· 1 shared Julie J. PurkaliD· 1 shared Justin P. IngramiD· 1 shared Lauren E. PopeiD· 1 shared Magdalena B. MurrayiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anlu ChenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedSep 5, 2025

Lipid composition differentiates ferroptosis sensitivity between in vitro and in vivo systems

Vivian S. Park, Lauren E. Pope, Justin P. Ingram…·Relja Popovic

This study shows that GPX4 inhibitor sensitivity differs between 2D and 3D cultures due to lipid composition changes, with 3D cultures showing resistance through PUFA displacement by MUFAs.

37 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky